共 47 条
[1]
Bedwell A.E., Elson C.J., Carter S.D., Dieppe P.A., Hutton C.W., Czudek R., Isolation and analysis of complement activating aggregates from synovial fluids of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies, Ann Rheum Dis, 46, pp. 55-64, (1987)
[2]
Male D.K., Roitt I.M., Molecular analysis of complement fixing rheumatoid synovial fluid immune complexes, Clin exp Immunol, 46, pp. 521-529, (1982)
[3]
Rademacher T.W., Network theory of glycosylation-etiologic and pathogenic implications of changes in IgG glycoform levels in autoimmunity, Sem Cell Biol, 3, (1992)
[4]
Rook G.A.W., Thompson S.J., Buckley M., Elson C.J., Brearly R., Lambert C., Whyte A., Rademacher T., The role of oil and agal-actosyl IgG in the induction of arthritis in rodent models, Eur J Immunol, 21, pp. 1027-1032, (1991)
[5]
Hitsumoto Y., Thompson S.J., Elson C.J., Relationship between interleukin-6 and pristane induced arthritis, Autoimmunity, 11, pp. 247-254, (1992)
[6]
Haragai M., Kitani A., Hara M., Hirose T., Norioka K.I., Susuki K., Rheumatoid adherent synovial cells produce Bcelldifferentiation factor activity neutralizable by antibody to Bcellstimulatory factor-2/Interleukin 6, J Rheumatol, 15, pp. 1616-1622, (1988)
[7]
Winchester R.J., Agnello V., Kunkel H.G., Gamma globulin complexes in synovial fluid of patients with rheumatoid arthritis. Partial characterisation and relationship to lowered complement levels, Clin exp Immunol, 6, pp. 689-706, (1970)
[8]
Zvaifler N.J., Breakdown products of C3 in human synovial fluids, Clin Invest, 48, pp. 1532-1542, (1969)
[9]
Dularay D., Dieppe P.A., Elson C.J., Depressed degranulation response of synovial fluid polymorphonuclear leukocytes from patients with rheumatoid arthritis to IgG aggregates, Clin exp Immunol, 79, pp. 195-201, (1990)
[10]
Dularay B., Dieppe P.A., Elson C.J., Oxidative response of polymorphonuclear leukocytes to synovial fluids from patients with rheumatoid arthritis, Ann Rheum Dis, 49, pp. 661-669, (1990)

